Addressing Perinatal Opioid Use Disorder

Women with opioid use disorder, who are pregnant or likely to become pregnant, face potentially adverse outcomes for themselves and their infants, including preterm labor, stillbirth, neonatal abstinence syndrome and maternal mortality.

Blue Cross Blue Shield of Michigan, the Blue Cross Blue Shield of Michigan Foundation and the Michigan Department of Health and Human Services are partnering on a new initiative called Addressing Perinatal Opioid Use Disorder, to support organizations working within the state's 10 Regional Perinatal Quality Collaboratives, or RPQC's.

The Addressing Perinatal Opioid Use Disorder initiative will award a total of $200,000 to begin new projects, enhance or expand existing projects to reduce opioid use and harm to women and their infants. The maximum grant awarded to any organization will be $75,000. The project period will run for 18 months.

This initiative will focus on prevention of and response to opioid use disorder among women, their children and infants during prenatal, pregnancy and postnatal stages. Funded projects will focus on service provision and must be a part of or support the strategic plans of the RPQC. Projects must be proposed and conducted by at least one non-profit member of the RPQC.

Proposals and application materials are due Aug. 31, 2019, and final decisions will be announced by the end of November. Submit your applications as a single PDF to innovations@bcbsm.com.